Drawing for MSD

USPTO serial 79400971

MSD

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
MCNAMARA, SHANA MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MSD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina S. Loza

Christina S. Loza Loza & Loza, LLP305 North Second Avenue, #127Upland, CA 91786United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, autoimmune, fungal, bacterial, parasitic diseases and disorders for human and veterinary use; vaccines for human and veterinary use; medicinal, pharmaceutical, therapeutic, and biological preparations for internal use and topical use for the treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, autoimmune, fungal, bacterial, parasitic diseases and disorders; medicated supplements for foodstuffs for animals; drug delivery patches, namely, transdermal patches for use in the treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, autoimmune, fungal, bacterial, parasitic diseases and disordersSECTION 70 - CANCELLED—
009Downloadable software and computer hardware for collecting, monitoring, analyzing, managing, processing, sharing and accessing patient health, medical, diagnostic, and healthcare data; downloadable software for use in the preparation and testing of pharmaceuticals; electronic downloadable publications in the nature of journal articles, press releases, fact sheets, data sheets, brochures, image files, manuals, guides, and reports in the fields of healthcare, pharmaceuticals, medicine, and animal health; downloadable software for providing information in the fields of healthcare, pharmaceuticals, medicine, and animal health; downloadable computer software for use in inventory, shipment and delivery management in the fields of healthcare, pharmaceuticals, medicine, and animal health; downloadable software and computer hardware for collecting, tracking, monitoring, analyzing, managing, processing, sharing and accessing information and data in the fields of animals and agriculture; radio-frequency identification (RFID) and electronic encoded identity tags for use in identifying and monitoring animals; electronic animal identification apparatus; microchips for use in animalsSECTION 70 - CANCELLED—
010Surgical apparatus and instruments for medical or veterinary use; medical instruments and apparatus for diagnosing and treating autoimmune, bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, infectious and urological diseases and disorders; inhalers for medical purposes, sold empty; injection and medical or veterinary infusion devices for administering pharmaceuticals; veterinary apparatus and instruments for dispensing pharmaceutical products, namely, drenching guns for animals and livestock, veterinary vaccine applicators, veterinary infusers and injectors, veterinary dosing devices, sutures, and temperature measuring systems for veterinary useSECTION 70 - CANCELLED—
035Business support services to start-up companies in the pharmaceutical, healthcare, veterinary, and biomedical fields by providing workspace containing technology equipment; business information services in the fields of healthcare, pharmaceuticals, medicine, and animal health; providing incentive award programs through issuance and processing of loyalty points for purchase of a company's goods and services in the fields of healthcare, pharmaceuticals, medicine, and animal health; administration of a program for enabling participants to obtain discounts on products and services in the fields of healthcare, pharmaceuticals, medicine, and animal health; provision of business, marketing, product sales and commercial information relating to pharmaceutical, medical, veterinary and healthcare products via a global communications network; retail, wholesale, and online retail store services featuring vaccines, pharmaceuticals, healthcare products, medicines, and veterinary products; distribution of advertising, marketing and promotional material in the fields of healthcare, pharmaceuticals, medicines, and animal health; business research and data analysis in the field of pharmaceutical drug developmentSECTION 70 - CANCELLED—
041Educational services, namely, conducting programs in the fields of medicine, healthcare, pharmaceuticals, and animal health, and distribution of educational materials in connection therewith.SECTION 70 - CANCELLED—
042Providing medical research information in the fields of pharmaceuticals, clinical trials, and veterinary preparations; medical, scientific, veterinary, and pharmaceutical research and development services; design and development of computer hardware and software in the fields of healthcare, pharmaceuticals, medicines, and animal health; medical and scientific research, namely conducting clinical trials for others; providing online non-downloadable software for collecting, monitoring, analyzing, managing, processing, sharing and accessing patient health, medical, diagnostic, and healthcare data; providing online non-downloadable software for use in the preparation and testing of pharmaceuticals; providing online non-downloadable software for providing information in the fields of healthcare, pharmaceuticals, medicines, and animal health; providing online non-downloadable software for use in inventory, shipment and delivery management in the fields of healthcare, pharmaceuticals, medicines, and animal health; providing online non-downloadable software for collecting, tracking, monitoring, analyzing, managing, processing, sharing and accessing information and data in the fields of animals and agricultureSECTION 70 - CANCELLED—
044Providing information in the fields of healthcare, pharmaceuticals, medicines, and animal health, including via a website; charitable services, namely, providing medical, veterinary and healthcare services in the nature of providing medication use and management information and mental health and wellness information to patients and caregivers; veterinary services; medical testing for diagnostic or treatment purposes; medical analysis services relating to the treatment and diagnosis of patientsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 20, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 5, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 12, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jan 29, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jan 29, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 24, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 24, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 4, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 4, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 4, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 4, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 4, 2025ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 5, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 5, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 30, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 27, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 27, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jun 27, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 27, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 27, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 27, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 9, 2025RFNTREFUSAL PROCESSED BY IB—
Jan 22, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 22, 2025RFRRREFUSAL PROCESSED BY MPU—
Dec 25, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 24, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2024DOCKASSIGNED TO EXAMINER—
Jul 29, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 29, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance